3,155 results match your criteria Pericardiocentesis

A novel in-plane technique ultrasound-guided pericardiocentesis via subcostal approach.

Ultrasound J 2022 May 21;14(1):20. Epub 2022 May 21.

Consultant Emergency Physician & ED Critical Care, Resuscitation & Emergency Critical Care Unit (RECCU), Trauma & Emergency Department, Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia.

Background: Cardiac tamponade occurs when fluid or blood, fills the pericardial space, and causes hemodynamic compromise due to compression of the heart. It is a potentially life-threatening condition, that requires rapid recognition and immediate treatment. Formerly, blind or surgical techniques were used, and it is associated with complications. Read More

View Article and Full-Text PDF

Tamponade with recurrent chylopericardium in patient with non-Hodgkin's lymphoma: chemotherapy is the key management after pericardiocentesis.

BMJ Case Rep 2022 May 17;15(5). Epub 2022 May 17.

Department of Cardiology and Vascular Medicine, Universitas Airlangga Hospital, Surabaya, East Java, Indonesia.

Cardiac tamponade, the accumulation of fluid in the pericardial space, leads to impaired venous return, loss of left ventricular preload and haemodynamic collapse. Chylopericardium is an unusual cause of the pericardial effusion. This is often secondary to malignancy. Read More

View Article and Full-Text PDF

Pericardial Effusion Secondary to Nilotinib in an Elderly Patient With Chronic Myelogenous Leukemia.

Cureus 2022 Apr 5;14(4):e23855. Epub 2022 Apr 5.

Cardiology, Mount Sinai Beth Israel/Icahn School of Medicine at Mount Sinai, New York City, USA.

Tyrosine kinase inhibitors (TKIs) are the first-line treatment for patients with chronic myelogenous leukemia (CML). Serositis, including pleural and pericardial effusions, is a frequent adverse event with some TKIs while less frequent with others. We present a case of a 76-year-old woman with CML on nilotinib who presented with progressive fatigue and was eventually found to have cardiac tamponade from a large pericardial effusion attributed to nilotinib. Read More

View Article and Full-Text PDF

Cardiac tamponade due to right atrial rupture.

Turk J Emerg Med 2022 Apr-Jun;22(2):104-107. Epub 2022 Apr 11.

Department of Emergency Medicine and Trauma, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Cardiac tamponade is a cardiac emergency that requires urgent intervention. Cardiac tamponade due to penetrating cardiac injury requires urgent thoracotomy. As per the guidelines, pericardiocentesis can be done as a bridge to thoracotomy. Read More

View Article and Full-Text PDF

Cardiac tamponade as the initial presentation of autoimmune polyglandular syndrome Type 2: a case report.

Eur Heart J Case Rep 2022 May 8;6(5):ytac145. Epub 2022 Apr 8.

Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.

Background: Cardiac tamponade is a rare but serious manifestation of autoimmune polyglandular syndrome Type 2 (APS 2). Patients often present with symptoms of thyroid dysfunction and adrenal insufficiency, but the insidious onset of the disease may lead to delayed diagnosis, which can progress rapidly to haemodynamic instability requiring urgent intervention.

Case Summary: A 39-year-old previously healthy male was admitted with cardiac tamponade complicated by cardiac arrest requiring emergent pericardiocentesis. Read More

View Article and Full-Text PDF

Simulation-based procedure training (SBPT) in rarely performed procedures: a blueprint for theory-informed design considerations.

Adv Simul (Lond) 2022 May 8;7(1):13. Epub 2022 May 8.

Faculty of Life Sciences and Medicine, King's College London, London, UK.

Simulation-based procedure training is now integrated within health professions education with literature demonstrating increased performance and translational patient-level outcomes. The focus of published work has been centered around description of such procedural training and the creation of realistic part-task models. There has been little attention with regards to design consideration, specifically around how simulation and educational theory should directly inform programme creation. Read More

View Article and Full-Text PDF

Clinical experience of the PK Papyrus covered stent in patients with coronary artery perforations: Results from a multi-center humanitarian device exemption survey.

Cardiovasc Revasc Med 2022 Apr 25. Epub 2022 Apr 25.

Division of Interventional Cardiology, MedStar Cardiovascular Research Network, MedStar Washington Hospital Center, 110 Irving Street, NW, #4B-1, Washington, DC 20010, USA. Electronic address:

Background/purpose: The PK Papyrus covered coronary stent system (Biotronik AG, Bülach, Switzerland) is intended for treatment of coronary artery perforation (CAP) and is approved for use under a Humanitarian Device Exemption (HDE) in the United States (US).

Methods/materials: The retrospective data analysis includes cases reported from the US PK Papyrus HDE post-market surveillance clinical dataset with CAP cited as the reason for PK Papyrus stent use.

Results: From April 2019 to July 2021, PK Papyrus device registration forms citing CAP as the reason for use were received for 1094 cases from 335 US hospital programs. Read More

View Article and Full-Text PDF

Left Ventricular Free-Wall Rupture After Late-Admission STEMI.

J Invasive Cardiol 2022 May;34(5):E416-E417

Rua Ramiro Barcelos 2350, Porto Alegre, RS, Brazil.

This case illustrates a rare but catastrophic complication of acute myocardial infarction, ie, acute rupture of the left ventricular free wall. The majority of patients have hemodynamic impairment on arrival, and a high level of suspicion is needed. Point-of-care echocardiogram is valuable for prompt diagnosis. Read More

View Article and Full-Text PDF

Pericardial Decompression Syndrome: A Case Series and Literature Review.

CJC Open 2022 Apr 9;4(4):420-423. Epub 2021 Dec 9.

Division of Cardiology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Cardiac tamponade is a medical emergency requiring prompt recognition and intervention to avoid potentially fatal consequences. We present a case series of ventricular dysfunction and cardiogenic shock following pericardiocentesis in 3 patients with pericardial effusions at The Ottawa Hospital between 2014 and 2020. This report highlights the need for monitoring post-pericardiocentesis and raises awareness of this phenomenon, particularly in patients with malignancy. Read More

View Article and Full-Text PDF

Acute Marginal Artery Laceration as a Complication of Pericardiocentesis.

JACC Case Rep 2022 Apr 20;4(8):501-504. Epub 2022 Apr 20.

Division of Cardiovascular Medicine, Saint Vincent Hospital, Worcester, Massachusetts, USA.

The safety of pericardiocentesis as a therapy for cardiac tamponade has improved since the advent of echocardiography-guided pericardiocentesis. The most life-threatening, albeit rare, complication is injury to the coronary vessels or ventricular wall resulting in recurrent tamponade. We present a rare case of acute marginal artery laceration resulting from pericardiocentesis. Read More

View Article and Full-Text PDF

Clinical outcomes and predictors of complications in patients undergoing leadless pacemaker implantation.

Heart Rhythm 2022 Apr 18. Epub 2022 Apr 18.

Division of Cardiovascular Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address:

Background: Leadless pacemakers have emerged as a viable alternative for traditional transvenous pacemakers to reduce the risk of device-related complications.

Objective: The purpose of this study was to examine the real-world clinical outcomes and complications associated with the implantation of leadless pacemaker devices.

Methods: Using the National Readmission Database (NRD), we examined patient demographics, and in-hospital and 30-day procedural outcomes after leadless pacemaker implantation from 2016-2018. Read More

View Article and Full-Text PDF

Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO.

Int J Cardiol 2022 Apr 26. Epub 2022 Apr 26.

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, MN, USA. Electronic address:

Background: The prevalence, treatment, and outcomes of balloon undilatable lesions encountered in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) have received limited study.

Methods: We examined the clinical characteristics and procedural outcomes of balloon undilatable lesions in the Prospective Global Registry for the Study of CTO Intervention (PROGRESS-CTO, NCT02061436).

Results: Of 6535 CTO PCIs performed between 2012 and 2022, 558 (8. Read More

View Article and Full-Text PDF

Pericardiocentesis or surgical drainage: A national comparison of clinical outcomes and resource use.

PLoS One 2022 28;17(4):e0267152. Epub 2022 Apr 28.

Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, CA, United States of America.

Background: While institutional series have sought to define the optimal strategy for drainage of pericardial effusions, large-scale comparisons remain lacking. Using a nationally representative sample, the present study examined clinical and financial outcomes following pericardiocentesis (PC) and surgical drainage (SD) in patients admitted for pericardial effusion and tamponade.

Methods: Adults undergoing PC or SD within 2 days of admission for non-surgically related pericardial effusion or tamponade were identified in the 2016-2019 Nationwide Readmissions Database. Read More

View Article and Full-Text PDF

Clinical Presentation and Management of Methicillin-Resistant Pericarditis-Systematic Review.

J Cardiovasc Dev Dis 2022 Mar 30;9(4). Epub 2022 Mar 30.

Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.

In the expanding era of antibiotic resistance, new strains of have emerged which possess resistance to traditionally used antibiotics (MRSA). Our review aimed to systematically synthesize information on previously described MRSA pericarditis cases. The only criterion for inclusion was the isolation of MRSA from the pericardial space. Read More

View Article and Full-Text PDF

Rapid resolution of severe pericardial effusion using anakinra in a patient with COVID-19 vaccine-related acute pericarditis relapse: a case report.

Eur Heart J Case Rep 2022 Apr 18;6(4):ytac123. Epub 2022 Mar 18.

Department of Internal Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Background: Pericarditis, along with myocarditis, is being increasingly reported after the coronavirus disease 2019 (COVID-19) vaccine, but the best treatment strategy in this specific setting is still unclear.

Case Summary: We report a case of acute pericarditis after the second dose of mRNA COVID-19 vaccine with recurrence of large pericardial effusion after a previous pericardiocentesis and anti-inflammatory drugs tapering. The patient was successfully treated with the recombinant interleukin-1 receptor antagonist anakinra, with full reabsorption of the pericardial effusion and an abrupt drop of the inflammatory markers within 72 h. Read More

View Article and Full-Text PDF

Septic pericardial disease and mediastinal abscessation in a cat with an intrathoracic needle foreign body.

J Vet Emerg Crit Care (San Antonio) 2022 Apr 20. Epub 2022 Apr 20.

Canada West Veterinary Specialists and Critical Care Hospital, Vancouver, British Columbia, Canada.

Objective: To describe the successful management of a cat with an intrathoracic sewing needle foreign body and septic pericardial effusion.

Case Summary: A 10-year-old neutered female domestic longhair cat was referred for an intrathoracic metallic foreign body identified via thoracic radiography. Two weeks prior, the cat may have ingested a sewing needle. Read More

View Article and Full-Text PDF

Spindle-cell sarcoma of the heart: A case report of a rare cause of cardiac mass.

Ann Card Anaesth 2022 Apr-Jun;25(2):220-224

Department of Cardiac Anaesthesia and Surgery, Wockhardt Hospitals, Mumbai, Maharashtra, India.

Spindle cell sarcoma of heart are the least reported primary cardiac tumours. We present a case of a 60-year-old man reported to us following successful resuscitation after cardiac arrest. This patient presented with symptoms of dyspnoea on exertion. Read More

View Article and Full-Text PDF

Successful management of life-threatening cardiac tamponade by pericardial aspiration in a boy following blunt trauma to the chest.

BMJ Case Rep 2022 Apr 12;15(4). Epub 2022 Apr 12.

Department of Medical Sciences, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, Oxfordshire, UK

A 7-year-old boy was presented with significant chest pain, reduced consciousness with haemodynamic instability following a minor blunt trauma to the chest. He was diagnosed to have a life-threatening pericardial effusion in FAST (Focused Assessment with Sonography for Trauma scan) ultrasound examination which was confirmed as haemopericardium causing cardiac tamponade in 2D echocardiogram. Emergency cardiac catheterisation ruled out active bleeding and prompt pericardiocentesis under fluoroscopy guidance rapidly restored patients' haemodynamic parameters. Read More

View Article and Full-Text PDF

Life-Threatening Cardiac Tamponade Secondary to COVID-19 Treated with Uniportal Video-Assisted Thoracoscopic Surgery: A Case Report.

Am J Case Rep 2022 Apr 9;23:e935839. Epub 2022 Apr 9.

Department of Cardiothoracic and Vascular Surgery, Rania Medical City Hospital, Rania, Sulaimani, Iraq.

BACKGROUND The COVID-19 outbreak emerged in December 2019 in Wuhan, China. COVID-19 is caused by the SARS-CoV-2 coronavirus and mostly affects the respiratory system but can also affect other organs, including the cardiovascular system. Furthermore, the most common cardiac complications include severe left ventricular dysfunction, acute myocardial injury, and arrhythmias. Read More

View Article and Full-Text PDF

A case of complete atrioventricular block associated with primary cardiac lymphoma reversed without cardiac pacemaker implantation.

J Int Med Res 2022 Apr;50(4):3000605221089780

Department of Cardiology, Shanghai Changzheng Hospital, the Second Affiliated Hospital of Naval Medical University, Shanghai, China.

Primary cardiac lymphoma (PCL) is a rare malignant lymphoma that is characteristically confined to the heart and/or pericardium. Here, the case of a 70-year-old male patient with complete atrioventricular block (AVB) associated with PCL is presented. The patient had a 10-month history of palpitation and electrocardiogram (ECG) showed a complete AVB. Read More

View Article and Full-Text PDF

Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.

Front Cardiovasc Med 2022 21;9:848091. Epub 2022 Mar 21.

Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.

Chimeric antigen receptor T (CAR-T) cell therapy has been shown to have substantial efficacy against refractory hematopoietic malignancies. However, it frequently causes cytokine release syndrome (CRS) as a treatment-specific adverse event. Although cardiovascular events associated with CAR-T cell therapy have been increasingly reported recently, pericardial disease is a rare complication and its clinical course is not well characterized. Read More

View Article and Full-Text PDF

[Clinical characteristics and risk factors of pericardial effusion after hematopoietic stem cell transplantation in children with thalassemia major].

Zhonghua Er Ke Za Zhi 2022 Apr;60(4):323-328

Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.

To investigate the characteristics, risk factors and outcomes of thalassemia major (TM) children with pericardial effusion (PE) after allo-geneic hematopoietic stem cell transplantation (allo-HSCT). Clinical data of 446 TM children received allo-HSCT at Shenzhen Children's Hospital between January 2012 and December 2020 were analyzed retrospectively. Patients were divided into PE and non-PE group according to the occurrence of PE. Read More

View Article and Full-Text PDF

Transient left ventricular dysfunction after therapeutic pericardiocentesis - Takotsubo cardiomyopathy or pericardial decompression syndrome.

Monaldi Arch Chest Dis 2022 Apr 1. Epub 2022 Apr 1.

Department of Cardiology, Holy Heart Hospital, Rohtak, Haryana.

We present a case of reversible left ventricular (LV) dysfunction with characteristic stress or "Takotsubo" cardiomyopathy (SCM) after therapeutic pericardiocentesis in a patient with tubercular pericardial effusion. SCM following pericardiocentesis is uncommon, as opposed to the well-defined entity, pericardial decompression syndrome (PDS). PDS is defined as a paradoxical deterioration of hemodynamics and development of severe biventricular dysfunction, cardiogenic shock, and pulmonary edema after uneventful, often large volume pericardiocentesis in patients of pericardial effusion. Read More

View Article and Full-Text PDF

Demographic, clinical and etiological profile of pericardial effusion in India: A single centre experience.

Indian J Tuberc 2022 Apr 21;69(2):220-226. Epub 2021 Aug 21.

Department of Cardiothoracic Vascular Surgery, King George's Medical University, Uttar Pradesh, India.

Introduction: Pericardial effusion (PE) is a life-threatening condition. However, there are very few Indian studies which determined etiological distribution. The current retrospective observational study was carried out to assess etiological factors responsible for PE in a tertiary care centre in India. Read More

View Article and Full-Text PDF

Survival following non-operative management of infected coronary artery aneurysm with infected pericardial effusion complicated by multi-organ failure: a case report.

Eur Heart J Case Rep 2022 Mar 16;6(3):ytac079. Epub 2022 Feb 16.

Waikato Hospital, Intensive Care Unit, Pembroke Street, Hamilton 3204, New Zealand.

Background: Infected coronary artery aneurysm with infected pericardial effusion is a very rare complication following percutaneous coronary intervention (PCI) and is associated with high mortality. Management options include open cardiothoracic surgery or non-operative management with pericardiocentesis. The best management option is currently unknown. Read More

View Article and Full-Text PDF

A Novel, Low-cost, Low-fidelity Pericardiocentesis Teaching Model.

West J Emerg Med 2021 Jul 19;22(4):931-936. Epub 2021 Jul 19.

Albany Medical Center, Department of Emergency Medicine and Department of Surgery, Albany, New York.

Introduction: Pericardiocentesis is a high-risk/low-frequency procedure important to emergency medicine (EM). However, due to case rarity it is not often performed on a patient during residency training. Because the coronavirus disease 2019 pandemic limited cadaver-based practice, we developed a novel, low-cost, low-fidelity pericardiocentesis model using three dimensional-printing technology to provide advances on prior home-made models. Read More

View Article and Full-Text PDF

Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy.

JAMA Cardiol 2022 May;7(5):529-538

Xijing Hypertrophic Cardiomyopathy Center, Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Importance: Patients with hypertrophic obstructive cardiomyopathy (HOCM) and drug-refractory symptoms and outflow gradients have limited nonsurgical treatment options. The feasibility of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA) has been reported previously; however, procedural and medium-term outcomes are unknown.

Objective: To describe the safety and medium-term outcomes of PIMSRA in a large patient cohort with drug-refractory HOCM. Read More

View Article and Full-Text PDF

Development of Pericardial Effusion in Non-small Cell Lung Cancer Is Associated with the Presence of EGFR/ALK Mutations.

Isr Med Assoc J 2022 Mar;24(3):135-139

Department of Internal Medicine F (Recanati), Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.

Background: No specific clinical or histological factors are recognized to be associated with the development of pericardial effusion in non-small cell lung cancer (NSCLC) other than a metastatic disease.

Objectives: To assess whether specific clinical and histological features are associated with development of pericardial effusion in patients with NSCLC.

Methods: A consecutive cohort of patients with NSCLC who presented with symptomatic pericardial effusion 2014-2017 was compared to a control group of patients with advanced NSCLC without pericardial effusion. Read More

View Article and Full-Text PDF

Review of chylopericardium.

Mediastinum 2022 25;6. Epub 2022 Mar 25.

Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, MA, USA.

Chylopericardium is a rare pathologic condition consisting of the accumulation of excess amounts of chylous fluid within the pericardial cavity. Most patients are asymptomatic at presentation; however, chest pressure, chest pain and lightheadedness have been reported, and the most common presenting symptom is shortness of breath. Patients are noted to have enlargement of the cardiac silhouette on routine chest radiograph, and evidence of a pericardial effusion on echocardiography. Read More

View Article and Full-Text PDF